Marion County Multiple Sclerosis Self-Help Group, Ocala, Florida





Trials in Florida

Enjoying Life One Day at a Time!
Home

Guestbook

Mentors

Mailing/Mentor Sign-up

blog

Suggestions/Ideas

Calendar

Activities With Signup

Activities With Directions

Seminars/Events

Resources

Christmas Page

Meeting

MCMSGroup Pictures/Collages,

Activity Sample Pics

Trials in Florida

MS Yard Sale Pics

Bowling Pictures

Pool Pics

Cards & Games Pics

Villages Bowling Oct Pics

Lunch Pics

Sea World Pics

Christmas Party Pics

Pet Pics

Pet Pic Submission Page

MCMS Group Video

Inspirational Stories

Share Your Day! Up Video

Forums

Online Chat Room

Humor/Games

MSFyi Newsletter

News from WebMD

New MS Legislation

Healthtalk MS

Other MS News

Items For Sale/Loan/Needed

Be An MS Activist

Kristie's MS Video

Free Hugs Video

ASA Adaptive Skiing

Villages Support Group

MS Walk Donations 2009

National M.S. Society

MS Air Fresh. Helps NMSS

M.S. Assoc. of America

MS Poem/Brighter CD - MSAA

M.S. Foundation

MS Items- Helps MSF

Dating with Disabilities

Caregivers

PatientsLikeMe.com

Progressive M.S.

Caregiver Info

Stu's Views & M.S. News

Bike MS

MSF Poker Run

MTRA Field Trip

In-Home Medical Care

Game MS - Help NMSS!

MS Walk 2008

Photo Gallery

Blog

Current Trials in Florida

1 Recruiting Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Fingolimod;   Drug: Fingolimod;   Drug: Fingolimod matching placebo
2 Recruiting Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Drug: BG00012
3 Recruiting Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Interferon beta 1-a;   Drug: glatiramer acetate;   Other: placebo
4 Recruiting Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: alemtuzumab;   Biological: alemtuzumab;   Biological: interferon beta-1a (Rebif®)
5 Recruiting Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: alemtuzumab;   Biological: interferon beta-1a (Rebif®)
6 Recruiting Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Drug: BG00012
7 Recruiting Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Drug: natalizumab;   Other: standard of care
8 Recruiting 12-Week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Interventions: Drug: CS-0777 tablets;   Drug: CS-0777 tablets;   Drug: CS-0777 tablets;   Drug: CS-0777 matching placebo tablets
9 Recruiting Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323
Condition: Multiple Sclerosis
Interventions: Drug: CDP323;   Drug: placebo;   Drug: CDP323
10 Recruiting A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: interferon beta-1a;   Drug: methylprednisolone;   Drug: ocrelizumab;   Drug: placebo
11 Recruiting Observational Study to Determine Impact of Multiple NAb Tests on Treatment Patterns Compared to the Usual Care of MS Patients Receiving High-Dose IFN Therapy.
Condition: Multiple Sclerosis
Intervention: Procedure: NAbs testing
12 Recruiting Evaluation of Natalizumab for thE Relief of MS Associated FatiGue
Condition: Multiple Sclerosis
Intervention:
13 Recruiting BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon â-1a (Avonex®)
Condition: Multiple Sclerosis
Interventions: Drug: laquinimod;   Drug: placebo;   Drug: Interferon â-1a (Avonex®)
14 Recruiting Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS
Condition: Pseudobulbar Affect (PBA)
Intervention: Drug: AVP-923









Email:  MCMSGroup@aol.com